Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We are proud to partner with the highly experienced laboratory team at YourGene Health to provide two advanced non-invasive prenatal testing options – the IONA® Test and the IONA® Care Test.
Both tests are highly sensitive and validated non-invasive prenatal test (NIPT) that assesses the risk of chromosomal conditions such as Trisomy 13 (Patau Syndrome), Trisomy 18 (Edwards Syndrome), Trisomy 21 (Down’s Syndrome), and sex chromosome abnormalities like Turner Syndrome.
Using just a single blood sample taken from the arm, the test analyses fetal DNA found in maternal blood, detectable from as early as 5 weeks, with optimal accuracy from 10 weeks onwards. The IONA® test is suitable for singleton, twin, and IVF pregnancies and delivers over 99% accuracy in detecting Trisomy 21, 18, and 13, with a false positive rate of less than 0.1% and a false negative rate of 0% based on data from over 12,000 pregnancies.
It is a safe, non-invasive alternative to procedures like amniocentesis or CVS and poses no risk to your baby. Results are typically available within 2–5 working days after your sample reaches the lab, often aligning with your 12-week scan. While incredibly reliable, the test is not diagnostic. A high-risk result indicates a strong likelihood of a chromosomal condition, and further diagnostic testing through your NHS care provider will be offered for confirmation and support.
The IONA® Test is Yourgene’s specialist NIPT, available from as early as 10 weeks of pregnancy. Using a simple maternal blood sample, it estimates the risk of your baby having:
Down’s syndrome (Trisomy 21)
Edwards’ syndrome (Trisomy 18)
Patau’s syndrome (Trisomy 13)
These conditions occur when three copies of a chromosome are present instead of the usual two. While Edwards’ and Patau’s syndromes are rarer than Down’s, they are associated with more serious outcomes. The IONA® Test provides a highly accurate, non-invasive screening option for reassurance in early pregnancy.
Includes detailed scan. Fetal Sex Determination on either test is optional
The IONA® Care Test offers an extended screening panel, also available from 10 weeks of pregnancy. Alongside screening for Down’s, Edwards’ and Patau’s syndromes (Trisomy 21, 18 and 13), it also screens for:
Sex Chromosomal Aneuploidies (SCA) – including conditions such as Klinefelter syndrome and Turner syndrome.
Autosomal Aneuploidies (AA) – affecting chromosomes 1–22, where extra or missing copies may be present.
This enhanced option is suitable for singleton and monochorionic (same-sex) twin pregnancies.
Includes a detailed ultrasound scan during your appointment.
Fetal Sex Determination on either test is optional